Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
A Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease. |
Chagas Disease | Phase2 |
Argentina Brazil Colombia United States View All
|
NCT06632600 |
|
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas |
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant, Prostatic Neoplasms, Castration-Resistant, Endometrial Cancer, Ovarian Clear Cell Carcinoma, Metastatic Castration-resistant Prostate Cancer | Phase1, Phase2 |
France Italy Poland South Korea Spain United Kingdom United States View All
|
NCT04104776 |
|
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer |
Early Breast Cancer | Phase3 |
Australia Canada China Germany Hong Kong Israel South Korea Taiwan Turkey (Türkiye) United States View All
|
NCT05827081 |
|
DFT383 in Pediatric Participants With Nephropathic Cystinosis |
Nephropathic Cystinosis | Phase1, Phase2 | United States | NCT06910813 |
|
A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US |
Immunoglobulin A Nephropathy | United States | NCT06952426 | |
|
Real-world Study on Secukinumab Effectiveness in Biologic-naïve Ankylosing Spondylitis (AS) Patients in Korea. |
Ankylosing Spondylitis | South Korea | NCT06905288 | |
|
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants |
Alzheimer Disease, Mild Cognitive Impairment | Phase1 |
France Spain |
NCT05469360 |
|
Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation |
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase | Phase4 | India | NCT06427811 |
|
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA). |
Juvenile Psoriatic Arthritis | Phase1 | United States | NCT06751238 |
|
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA |
ANCA Associated Vasculitis (AAV) | Phase2 |
Israel Japan Saudi Arabia Singapore Switzerland United States View All
|
NCT06868290 |